We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$89.2M
AUM Growth
-$19.6M
Cap. Flow
+$505K
Cap. Flow %
0.57%
Top 10 Hldgs %
96.53%
Holding
13
New
–
Increased
1
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$4.68M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$2.01M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$1.38M
3
ATRA icon
Atara Biotherapeutics
ATRA
+$784K

Sector Composition

Rank Sector Weight
1 Healthcare 96.57%
2 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.2B
$26.9M 30.17%
8,282,204
+2,432,204
+42% +$4.68M
IVVD icon
2
Invivyd
IVVD
$218M
$21M 23.53%
6,398,250
– –
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$394M
$9.85M 11.04%
715,880
– –
STOK icon
4
Stoke Therapeutics
STOK
$2.11B
$6.96M 7.81%
527,150
– –
BBIO icon
5
BridgeBio Pharma
BBIO
$16.5B
$4.23M 4.75%
466,200
– –
CRIS icon
6
Curis
CRIS
$7.83M
$4.18M 4.68%
10,608
– –
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.11M 4.61%
61,200
-21,700
-26% -$1.38M
TGTX icon
8
TG Therapeutics
TGTX
$7.62B
$3.09M 3.46%
726,200
-321,700
-31% -$2.01M
CYPH
9
Cypherpunk Technologies Inc
CYPH
$73.3M
$3.06M 3.43%
266,440
– –
VERV
10
DELISTED
Verve Therapeutics
VERV
$2.73M 3.06%
178,500
– –
ATRA icon
11
Atara Biotherapeutics
ATRA
$76.1M
$2.1M 2.35%
10,770
-4,804
-31% -$784K
PRQR icon
12
ProQR Therapeutics
PRQR
$265M
$779K 0.87%
1,001,800
– –
NEXI
13
DELISTED
NexImmune, Inc. Common Stock
NEXI
$215K 0.24%
5,338
– –

Similar funds

NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return
WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53.2M AUM 13.56% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return
FRGX
First Reserve GP XIII Stamford, Connecticut $52.9M AUM 17.37% 1-Year Est. Return

M28 Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, M28 Capital Management held 13 positions worth $89.2M, down 18% from $109M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. M28 Capital Management opened no new positions and made no exits, leaving the 13-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Financials.

  • M28 Capital Management added most to Wave Life Sciences in Q2 2022, an estimated $4.68M increase.
  • M28 Capital Management's biggest Q2 2022 reduction was TG Therapeutics, cutting an estimated $2.01M.
  • M28 Capital Management's ten largest holdings make up 97% of its $89.2M portfolio in Q2 2022.
  • M28 Capital Management opened 0 new positions and closed 0 in Q2 2022.
  • M28 Capital Management's portfolio value fell 18% quarter-over-quarter to $89.2M.

Based on M28 Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.